Literature DB >> 6145046

Improved sensitivity of islet cell cytoplasmic antibody assay in diabetics.

C Pilcher, R B Elliott.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6145046     DOI: 10.1016/s0140-6736(84)91842-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Assessment of precision, concordance, specificity, and sensitivity of islet cell antibody measurement in 41 assays.

Authors:  E Bonifacio; C Boitard; H Gleichmann; M A Shattock; J L Molenaar; G F Bottazzo
Journal:  Diabetologia       Date:  1990-12       Impact factor: 10.122

2.  Effect of cyclosporin A treatment on the production of antibody in insulin-dependent (type I) diabetic patients.

Authors:  C Boitard; G Feutren; L Castano; M Debray-Sachs; R Assan; J Hors; J F Bach
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

3.  Islet cell and other organ-specific autoantibodies in all children developing type 1 (insulin-dependent) diabetes mellitus in Sweden during one year and in matched control children.

Authors:  M Landin-Olsson; A Karlsson; G Dahlquist; L Blom; A Lernmark; G Sundkvist
Journal:  Diabetologia       Date:  1989-06       Impact factor: 10.122

4.  Prolonged incubation in the two-colour immunofluorescence test increases the prevalence and titres of islet cell antibodies in type 1 (insulin-dependent) diabetes mellitus.

Authors:  M L Olsson; G Sundkvist; A Lernmark
Journal:  Diabetologia       Date:  1987-05       Impact factor: 10.122

5.  Islet cell antibody heterogeneity among type 1 (insulin-dependent) diabetic patients.

Authors:  J Timsit; S Caillat-Zucman; H Blondel; P Chédin; J F Bach; C Boitard
Journal:  Diabetologia       Date:  1992-08       Impact factor: 10.122

6.  Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus.

Authors:  S Caillat-Zucman; H J Garchon; J Timsit; R Assan; C Boitard; I Djilali-Saiah; P Bougnères; J F Bach
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

7.  Prevalence of cytoplasmatic islet cell antibodies and insulin autoantibodies is increased in subjects with genetically defined high risk for insulin-dependent diabetes mellitus.

Authors:  B Kuglin; J Bertrams; C Linke; F A Gries; H Kolb
Journal:  Klin Wochenschr       Date:  1989-01-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.